Given that DM involves complement-mediated microangiopathy the inactive C4 fragmented peptide, C4d is predominantly seen in the muscle biopsy samples of these patients, as well as in nonspecific myositis patients, as a marker of complement activation and membrane attack complex (MAC) formation [85]. This evidence concerns the gene C4A and diabetes mellitus.